Senior insider sale
CEO at EAGLE PHARMACEUTICALS, INC. — senior position signals high conviction
$299.9K
20.25K shares
What this filing means
TARRIFF SCOTT plans to sell 20.25K shares of EAGLE PHARMACEUTICALS, INC. valued at approximately $299.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/3/2023ACC: 0001972649-23-000003
DirectorOfficer· CEO
Since Jun 2018
20.25K
Shares to sell
$299.9K
Approx. market value
10.73K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Executive Compensation
Cash
1/5/2020
5.71KExecutive Compensation
Cash
1/23/2019
5.03KTotal acquired10.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/5/2020 | Executive Compensation Cash | 5.71K | — |
1/23/2019 | Executive Compensation Cash | 5.03K | — |
| Total | 10.73K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
9.51K
Market value
$144.9K
10/2/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.73K
Market value
$155.0K
10/3/2023
Total
Units
20.25K
Value
$299.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/2/2023 | 9.51K | $144.9K | — | Completed |
| Planned — Approximate Date | ||||
10/3/2023 | 10.73K | $155.0K | NASDAQ | Planned |
| Total | 20.25K | $299.9K | ||